Daytime napping and increased risk of incident respiratory diseases: symptom, marker, or risk factor?

Sleep Medicine

Volumn 23, Issue , 2016, Pages 12-15

  Leng, Yue ^a,d   Wainwright, Nick W J ^a   Cappuccio, Francesco P ^b   Surtees, Paul G ^a   Hayat, Shabina ^a   Luben, Robert ^a   Brayne, Carol ^c   Khaw, Kay Tee ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF WARWICK   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cohort study; Incidence; Napping; Respiratory; Sleep

Indexed keywords

HYPNOTIC AGENT; BIOLOGICAL MARKER;

ADULT; AGE; AGED; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CHRONIC RESPIRATORY TRACT DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; EDUCATIONAL STATUS; EMPLOYMENT STATUS; EUROPE; FEMALE; HEALTH STATUS; HIGH RISK POPULATION; HOSPITAL ADMISSION; HUMAN; INCIDENCE; LOWER RESPIRATORY TRACT; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MORTALITY; NIGHT WORK; PHYSICAL ACTIVITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESPIRATORY TRACT DISEASE; RISK ASSESSMENT; RISK FACTOR; SELF REPORT; SEX; SLEEP PATTERN; SLEEP TIME; SMOKING; SOCIAL CLASS; SYMPTOM; BREATHING DISORDER; HABIT; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL; PSYCHOLOGY; SLEEP;

BIOMARKERS; FEMALE; HABITS; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RESPIRATION DISORDERS; RISK FACTORS; SLEEP;

EID: 84982806695     PISSN: 13899457     EISSN: 18785506     Source Type: Journal    
DOI: 10.1016/j.sleep.2016.06.012     Document Type: Article

References (17)

1. [1] McNicholas, W.T., Verbraecken, J., Marin, J.M., Sleep disorders in COPD: the forgotten dimension. Eur Respir Rev 22 (2013), 365–375.
2. [2] Leng, Y., Wainwright, N.W.J., Cappuccio, F.P., et al. Daytime napping and the risk of all-cause and cause-specific mortality: a 13-year follow-up of a british population. Am J Epidemiol 179 (2014), 1115–1124.
3. [3] Stang, A., Daytime napping and health consequences: much epidemiologic work to do. Sleep Med 16 (2015), 809–810.
4. [4] Zhong, G., Wang, Y., Tao, T., et al. Daytime napping and mortality from all causes, cardiovascular disease, and cancer: a meta-analysis of prospective cohort studies. Sleep Med 16 (2015), 811–819.
5. [5] Masa, J.F., Rubio, M., Pérez, P., et al. Association between habitual naps and sleep apnea. Sleep 29 (2006), 1463–1468.
6. [6] Day, N., Oakes, S.A., Luben, R., et al. EPIC-Norfolk: study design and characteristics of the cohort. Br J Cancer 80 (1999), 95–103.
7. [7] Young, T., Shahar, E., Nieto, F.J., et al. Predictors of sleep-disordered breathing in community-dwelling adults: the Sleep Heart Health Study. Arch Intern Med 162 (2002), 893–900.
8. [8] Lavie, P., Herer, P., Hoffstein, V., Obstructive sleep apnoea syndrome as a risk factor for hypertension: population study. BMJ 320 (2000), 479–482.
9. [9] Tishler, P. V, Larkin, E.K., Schluchter, M.D., et al. Incidence of sleep-disordered breathing in an urban adult population: the relative importance of risk factors in the development of sleep-disordered breathing. JAMA 289 (2003), 2230–2237.
10. [10] Young, T., Evans, L., Finn, L., et al. Estimation of the clinically diagnosed proportion of sleep apnea syndrome in middle-aged men and women. Sleep 20 (1997), 705–706.
11. [11] Patel, S., Malhotra, A., Gao, X., et al. A prospective study of sleep duration and pneumonia risk in women. Sleep 35 (2012), 97–101.
12. [12] Leng, Y., Ahmadi-Abhari, S., Wainwright, N.W.J., et al. Daytime napping, sleep duration and serum C reactive protein: a population-based cohort study. BMJ Open, 4, 2014, e006071.
13. [13] Sutherland, E.R., Martin, R.J., Airway inflammation in chronic obstructive pulmonary disease. J Allergy Clin Immunol 112 (2003), 819–827.
14. [14] Vestbo, J., Hurd, S.S., Agustí, A.G., et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 187 (2013), 347–365.
15. [15] Liukkonen, T., Räsänen, P., Ruokonen, A., et al. C-reactive protein levels and sleep disturbances: observations based on the Northern Finland 1966 Birth Cohort study. Psychosom Med 69 (2007), 756–761.
16. [16] Ferrie, J.E., Kivimäki, M., Akbaraly, T.N., et al. Associations between change in sleep duration and inflammation: findings on c-reactive protein and interleukin 6 in the whitehall II study. Am J Epidemiol 178 (2013), 956–961.
17. [17] Janson, C., De Backer, W., Gislason, T., et al. Increased prevalence of sleep disturbances and daytime sleepiness in subjects with bronchial asthma: a population study of young adults in three European countries. Eur Respir J 9 (1996), 2132–2138.